Surenano Science closes $245,000 private placement

Mr. Charles MaLette reports SURENANO CLOSES FINANCING Surenano Science Ltd. has closed a private placement financing of 2.45 million common shares at a price of 10 cents per share. Total proceeds of $245,000 were received by the company, including $85,000 in debt conversion. The company intends to use the cash proceeds for operating expenses, including legal and audit fees, and general working capital. No part of the proceeds will be used in connection with investor relations activities. All securities issued in the private placement will be subject to a four-month-and-a-day hold period. A related party, Charles Malette, participated in the private placement, purchasing shares for $110,000 cash and converting $85,000 in debt owed to him by the company. These investments into Surenano are exempt from valuation and minority shareholder approval requirements under National Instrument 61-101 because they amount to less than 25 per cent of capitalization. On completion of the debt settlement Mr. Malette will own 9,621,600 shares of the company (40 per cent of common shares then issued). Mr. MaLette is the president, secretary and director of Surenano. The other participants in the private placement are arm's-length parties. About Surenano Science Ltd. The business of Surenano Science is the sale and distribution of the Surenano surfactant, which is a ready-to-mix food grade compound that provides the base for high performance nanoemulsions to create incredibly homogeneous and stable products while maximizing bioavailability, clarity and taste. The company has an exclusive licence to distribute the Surenano surfactant within Canada; Oklahoma, United States; and Colorado, United States. We seek Safe Harbor.